scispace - formally typeset
S

Sara Ambrosino

Researcher at Utrecht University

Publications -  23
Citations -  2487

Sara Ambrosino is an academic researcher from Utrecht University. The author has contributed to research in topics: Autism spectrum disorder & Autism. The author has an hindex of 10, co-authored 14 publications receiving 1567 citations. Previous affiliations of Sara Ambrosino include Goethe University Frankfurt.

Papers
More filters
Journal ArticleDOI

Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis

Martine Hoogman, +92 more
TL;DR: Lifespan analyses suggest that, in the absence of well powered longitudinal studies, the ENIGMA cross-sectional sample across six decades of ages provides a means to generate hypotheses about lifespan trajectories in brain phenotypes.
Journal ArticleDOI

HHS Public Access

Martine Hoogman, +247 more
Journal ArticleDOI

Typical development of basal ganglia, hippocampus, amygdala and cerebellum from age 7 to 24

TL;DR: Subcortical structures appear to not yet be fully developed in childhood, similar to the cerebral cortex, and continue to show maturational changes into adolescence, and there is substantial heterogeneity between the developmental trajectories of these structures.
Journal ArticleDOI

Brain Imaging of the Cortex in ADHD: A Coordinated Analysis of Large-Scale Clinical and Population-Based Samples

Martine Hoogman, +128 more
TL;DR: Subtle differences in cortical surface area are widespread in children but not adolescents and adults with ADHD, confirming involvement of the frontal cortex and highlighting regions deserving further attention.
Journal ArticleDOI

The EU-AIMS Longitudinal European Autism Project (LEAP): design and methodologies to identify and validate stratification biomarkers for autism spectrum disorders

Eva Loth, +71 more
- 23 Jun 2017 - 
TL;DR: LEAP is to date the largest multi-centre, multi-disciplinary observational study worldwide that aims to identify and validate stratification biomarkers for ASD and is expected to enable it to confirm, reject and refine current hypotheses of neurocognitive/neurobiological abnormalities.